Citizen in a RepublicNH Bill Briefing
← All bills

HB 1702 · 2026 · House · Judiciary Committee

Abortion pill reversal notice requirement

AI-generated

relative to notice requirements and enforcement for pharmacies dispensing medications intended to induce chemical abortions.

Requires medical facilities and pharmacies dispensing mifepristone or other chemical abortion drugs to post a notice about potential abortion pill reversal, sets signage requirements by facility type, and creates felony and civil penalties for noncompliance.AI-generated

Status

Committee recommended Inexpedient to Legislate; died at adjournment · February 27, 2026
  1. ✓Introduced
  2. ✕House
  3. Senate
  4. Governor
  5. Law

Analysis

This bill: I. Defines "chemical" and "medical abortion" drugs. II. Requires medical facilities and pharmacies that provides chemical abortion drugs to post a standardized notice regarding the potential reversibility of mifepristone. III. Establishes signage requirements by facility type, imposes a class B felony for intentional noncompliance, and authorizes civil actions for failure to provide the required notice.

From the bill's official ANALYSIS section.

Official record

Bill page — docket & status

gc.nh.gov · the authoritative source

Sponsors

Rep. Samuel FarringtonRPrime
  • Rep. Jeanine NotterRAssistant Majority Leader
  • Sen. Kevin AvardRDeputy Majority Whip

Also: Rep. Maureen MooneyR, Rep. Mark PearsonR, Rep. Kristine PerezR, Rep. John SellersR, Rep. James ThibaultR, Rep. Cindy BennettR, Rep. Matt Sabourin dit ChoinièreR

Public testimony

1,013 signed in online · 230 wrote testimony

0% support100% oppose0% neutral

Against"Abortion reversal" claim is not supported by science

AI-generatedLeading arguments, summarized by the testimony tool.

Read the arguments

In their wordsVerbatim, exactly as submitted

“Again stop making women’s healthcare the business of our government, keep your morals to yourself and out of our healthcare. Let medical professionals and their patients make their own choices and leave propaganda out of it.”
— Arwen Mellor, Rindge · Myselfur governments.opposes
“To: House Health, Human Services and Elderly Affairs Committee From: Michael Courville, Manchester, NH Date: February 5, 2026 Subject: HB1702 – In Opposition Dear Chairman and Members of the Committee, My name is Michael Courville, and I am a resident of Manchester.…”
— Michael Courville, Manchesteropposes
“This bill would require inaccurate medical information to be posted in medical facilities. There is no sound evidence of being able to reverse the outcome of mifepristone. Claiming it can be is medical misinformation and is harmful to those seeking care.”
— Serena Funai, Nashuaopposes

Verbatim excerpts of submitted testimony, quoted from the testimony tool.

Read the testimony · as of Aug 12, 2026

Hearings

  • 2026-02-0910:00 amHouse JudiciaryGP 158Public hearing
  • 2026-02-1310:00 amHouse JudiciaryGP 158Public hearing

Legislative history

  1. Jan 7, 2026HouseIntroduced 01/07/2026 and referred to Judiciary HJ 1 P. 32
  2. Feb 9, 2026HousePublic Hearing: 02/09/2026 01:00 pm GP 158
  3. Feb 13, 2026HouseExecutive Session: 02/13/2026 10:00 am GP 158
  4. Feb 13, 2026HouseCommittee Report: Inexpedient to Legislate 02/13/2026 (Vote 17-0; RC) HC 10 P. 102

Coverage

No reporting linked yet.

Documents (PDF)

Bill text & amendments link direct to gc.nh.gov; committee reports stream from the state record.